The reason why such antibody response is preserved, despite the decline of CD4 T-lymphocyte counts in HIV-TB patients, has been related to the novel CD1-restricted lipid antigen presentation pathway [33], [34]. The gene discussed is CD4; the disease is tuberculosis.